A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Mol Hepatol
Main Authors: Yang, Hyun, Woo, Hyun Young, Lee, Soon Kyu, Han, Ji Won, Jang, Bohyun, Nam, Hee Chul, Lee, Hae Lim, Lee, Sung Won, Song, Do Seon, Song, Myeong Jun, Oh, Jung Suk, Chun, Ho Jong, Jang, Jeong Won, Lozada, Angelo, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497665/
https://ncbi.nlm.nih.gov/pubmed/28494528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados